Inpatient and Outpatient Orderable

Glucopsychosine

Synonyms

GLUCOPSYCHOSINE
GPSYPL
LAB14019

Cerner Name

Clinical Info

Second-tier test when newborn screening results with reduced beta-glucosidase (GBA) activity are identified
Diagnosis and monitoring of patients with Gaucher disease using plasma specimens
Supporting a biochemical diagnosis of Gaucher disease
Monitoring a patient's response to treatment
This test is not useful for identifying carriers of GBA variants.

Specimen Sources

Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous

Specimen Types

Blood

Container

Lavender Top Tube

Collection Instructions

Container/Tube; lavender Op EDTA tube
Specimen; 0.3 mL plasma ( 0.25 mL min)

Specimen Volume

0.3 mL plasma (0.25 mL min)

Transport Instructions

Frozen

Specimen Stability

Unacceptable Room Temperature or Refrigerated
65 Days Frozen

Methodology

LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY (LC-MS/MS)

Days Performed

TAT: 4-8 Days

Performing Laboratory

Mayo medical Laboratories

CPT

82542

PDM

245434

Only Orderable at Locations:

Orderable Everywhere

Results

Component Name	Base Name	Common Name	External Name
GLUCOPSYCHOSINE INTERPRETATION	GLUCOPSYINT	GLUCOPSYCHOSINE INTERP	Glucopsychosine Interpretation
GLUCOPSYCHOSINE	GLUCOPSY	GLUCOPSYCHOSINE	Glucopsychosine
GLUCOPSYCHOSINE REVIEWED BY	GLUCOPSYRVB	GLUCOPSYCHOSINE REVIEWED BY	Glucopsychosine Reviewed By

Result Interpretation

Cutoff: < or =0.003 nmol/mL

Forms

LAB14019

Search: .supercomplete-item { width: 600px; white-space: nowrap; overflow: hidden; text-overflow: ellipsis; } $(document).ready(function() { $("#search_input").supercomplete(); });